Status:
COMPLETED
Minimal-Dose Resistance Training for Improving sIgA and Cortisol
Lead Sponsor:
Universidad Francisco de Vitoria
Conditions:
Resistance Training
Immune System
Eligibility:
All Genders
18-30 years
Phase:
NA
Brief Summary
Whereas the role of endurance training on immune function has been widely studied, little is known about the role of resistance training (RT). In this cross-over randomized controlled study, it will b...
Eligibility Criteria
Inclusion
- 18-30 years
- Sedentary
Exclusion
- to have had COVID-19 during the last 3 months
- to have been vaccinated against COVID-19 during the last 3 months
- physical limitations or health problems
Key Trial Info
Start Date :
February 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 24 2022
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT05221996
Start Date
February 1 2022
End Date
March 24 2022
Last Update
May 17 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universidad Francisco de Vitoria
Pozuelo de Alarcón, Madrid, Spain, 28223